Media Coverage

Our commercial intelligence and analysis are used by the Financial Times, the Wall Street Journal, Forbes, Nature, and Reuters, among others.

Take a look at the latest Evaluate and Evaluate Vantage coverage. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at media@evaluate.com.

Latest Media Coverage

Nature Reviews Drug Discovery

Top companies and drugs by sales in 2020

Having supplanted Novartis as the biggest pharma company by prescription sales in 2019, Roche managed to hang onto the title in 2020.

Browse the archive

FierceBiotech

Biotech's top 10 money raisers of 2020

In 2020, the biotech sector raised just under $20 billion, outstripping 2018 on every measure, except the total number of financing rounds. 2020 saw 448 venture financing…

Nature Reviews Drug Discovery

Top companies and drugs by sales in 2020

Having supplanted Novartis as the biggest pharma company by prescription sales in 2019, Roche managed to hang onto the title in 2020.

Nature Biopharma Dealmakers

Next-generation therapeutics sustain momentum

The next-generation therapeutics space has continued to progress on several fronts in the past 12 months, but this could be set to change as the industry copes with the…